Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 2
2018 3
2019 5
2020 6
2021 5
2022 7
2023 5
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Burden of disease of chronic pain in Ecuador.
Lasalvia P, Gil-Rojas Y, Rosselli D. Lasalvia P, et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Jun;23(5):547-554. doi: 10.1080/14737167.2023.2193689. Epub 2023 Mar 29. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 36946473
Burden of disease of chronic pain in Colombia.
Lasalvia P, Gil-Rojas Y, Rosselli D. Lasalvia P, et al. Expert Rev Pharmacoecon Outcomes Res. 2022 Dec;22(8):1261-1267. doi: 10.1080/14737167.2022.2125872. Epub 2022 Sep 25. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 36106600
Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia.
Soto-Mora JA, Gómez-Espitia LM, Lasalvia P, Castellanos Moreno CA, Casallas Vanegas CA, Londoño Gutiérrez SA. Soto-Mora JA, et al. Among authors: lasalvia p. Int J Technol Assess Health Care. 2023 Jul 21;39(1):e48. doi: 10.1017/S0266462323000442. Int J Technol Assess Health Care. 2023. PMID: 37476982 Free PMC article.
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: lasalvia p. Dermatol Ther. 2020 Mar;33(2):e13145. doi: 10.1111/dth.13145. Epub 2019 Nov 14. Dermatol Ther. 2020. PMID: 31664762
Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis.
Lasalvia P, Barahona-Correa JE, Romero-Alvernia DM, Gil-Tamayo S, Castañeda-Cardona C, Bayona JG, Triana JJ, Laserna AF, Mejía-Torres M, Restrepo-Jimenez P, Jimenez-Zapata J, Rosselli D. Lasalvia P, et al. J Diabetes Sci Technol. 2016 Jun 28;10(4):959-66. doi: 10.1177/1932296816633721. Print 2016 Jul. J Diabetes Sci Technol. 2016. PMID: 26920639 Free PMC article. Review.
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: lasalvia p. Dermatol Ther. 2020 Aug 5:e14135. doi: 10.1111/dth.14135. Online ahead of print. Dermatol Ther. 2020. PMID: 32761749 Review.
34 results